Indeed, there is a highly upregulated expression of caspase-1 in human MCI and AD brains and mice carrying Nlrp3(-/-) or Casp1(-/-) mutations were largely protected from the neural deficits associated with early-onset AD (Heneka et al., 2013). Here, CASP1 is linked to Alzheimer disease.